DJIA 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%

Sarepta Therapeutics

NASDAQ: SRPT

36.91 1.40 (3.94%)

Quote as of

company name or ticker

Recent Quotes

SRPT $36.91 3.94%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $35.51
Previous Close $35.51
Daily Range $35.14 - $37.11
52-Week Range $2.60 - $45.00
Market Cap $1.2B
P/E Ratio -6.25
Dividend (Yield) $0.00 (0.0%)
Volume 1,378,036
Average Daily Volume 2,262,337
Current FY EPS -$3.68

Sector

Healthcare

Industry

Drugs

Sarepta Therapeutics (SRPT) Description

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology. Website: http://www.sareptatherapeutics.com/

News & Commentary Rss Feed

Sarepta Therapeutics Inc (SRPT): Today's Featured Drugs Winner

2 BioPharma Catalyst Trades Set to Break-Out With One Strong Acquisition Target

2 BioPharma Catalyst Trades And 1 Strong Acquisition Target Rumored To Be In Play

3 Biotech Stocks With Potential

Biotech Stock Mailbag: Synta, Zogenix, Sarepta, Amarin

Sarepta Therapeutics' CEO Discusses Q1 2013 Results - Earnings Call Transcript

Leaders of TheStreet's Drug Approval Contest

April's Unhealthiest Stocks

These three health-care picks nosedived last month on earnings and disappointing drug data.

3 Biggest Biotech Crashes in April

When biotechs fall, they fall hard. These three fell the hardest in April.

Sarepta Therapeutics Inc (SRPT): Today's Featured Drugs Winner

See More SRPT News...

SRPT's Top Competitors

SRPT $36.91 (3.94%)
Current stock: SRPT
AMGN $105.63 (0.63%)
Current stock: AMGN
GILD $56.30 (2.44%)
Current stock: GILD
BIIB $226.85 (-0.50%)
Current stock: BIIB